Loading...
XNAS
NXL
Market cap22mUSD
Jun 06, Last price  
1.29USD
1D
8.40%
1Q
-45.80%
IPO
-23.67%
Name

Nexalin Technology Inc

Chart & Performance

D1W1MN
P/E
P/S
131.34
EPS
Div Yield, %
Shrs. gr., 5y
4.83%
Rev. gr., 5y
-4.04%
Revenues
169k
+52.35%
207,383242,914144,0651,321,357110,748168,721
Net income
-8m
L+63.64%
-5,021,190-3,482,167-6,160,323-1,925,813-4,648,709-7,607,182
CFO
-4m
L+2.84%
-678,336-863,474-1,076,791-2,215,699-3,835,384-3,944,390

Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
IPO date
Sep 16, 2022
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
169
52.35%
111
-91.62%
1,321
817.20%
Cost of revenue
7,923
7,729
4,552
Unusual Expense (Income)
NOPBT
(7,755)
(7,618)
(3,230)
NOPBT Margin
Operating Taxes
(5)
228
Tax Rate
NOPAT
(7,750)
(7,618)
(3,458)
Net income
(7,607)
63.64%
(4,649)
141.39%
(1,926)
-68.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,516
8,549
BB yield
-17.76%
-156.64%
Debt
Debt current
9
751
Long-term debt
4
60
Deferred revenue
Other long-term liabilities
Net debt
(3,480)
(3,031)
(6,183)
Cash flow
Cash from operating activities
(3,944)
(3,835)
(2,216)
CAPEX
Cash from investing activities
(578)
4,453
(6,795)
Cash from financing activities
4,516
(200)
8,512
FCF
(7,740)
(7,621)
(4,297)
Balance
Cash
3,480
2,948
6,994
Long term investments
96
Excess cash
3,471
3,039
6,928
Stockholders' equity
(84,632)
(77,031)
(72,346)
Invested Capital
88,308
80,190
78,580
ROIC
ROCE
EV
Common stock shares outstanding
9,216
7,357
7,287
Price
2.76
581.82%
0.40
-45.95%
0.75
 
Market cap
25,436
754.08%
2,978
-45.43%
5,458
 
EV
21,956
(53)
(726)
EBITDA
(7,740)
(7,614)
(3,230)
EV/EBITDA
0.01
0.22
Interest
39
59
Interest/NOPBT